The patient is also anticoagulated on Coumadin currently.
Abdominal aortic aneurysm repair fifteen years ago.
ADMITTING MEDICATIONS:  Avandia 4.0 mg po q day, Glucotrol 10 mg po bid, Avalide one tablet po q day, and thyroid hormone 2.0 mg po q day.
HOSPITAL COURSE:  In the Emergency Department, the patient was initially treated with intravenous fluids and packed red blood cells, fresh frozen plasma, and vitamin K for an INR of 7.2, as well as a hematocrit of 22 which was down from her baseline of approximately 42.
The patient was then transferred to the Medical Intensive Care Unit where she was found to have a hematocrit of 18 and received three additional units of packed red blood cells.
In the Medical Intensive Care Unit subsequent nasogastric lavage was performed and revealed positive clots and blood in her gastric contents.
The patient's hematocrit was then found to be 25 and she received two additional units of packed red blood cells.
In addition, in the Medical Intensive Care Unit, the patient also received three units of fresh frozen plasma and was started on Protonix 80 mg IV q day, Robitussin 5.0 mL to 10 mL po q six to twelve hours, and an insulin sliding scale.
Gastrointestinal:  After the patient's hematocrit stabilized and her INR was normalized, she went for a colonoscopy and esophagogastroduodenoscopy on hospital day three.
The patient was then started on Protonix 80 mg IV which was later changed to 80 mg po q day.
Pulmonary:  At the time of her hospitalization, the patient had been taking Robitussin for several days for a nonproductive cough.
During her hospitalization, the patient experienced significant shortness of breath and desaturations into the 80s on two to three liters of supplemental oxygen.
Her maintenance IV fluids were decreased and she was started on Albuterol and Atrovent nebulizers and responded well to these.
While she experienced continued dyspnea on exertion, her oxygen requirement decreased from four to one to two liters at the time of discharge.
She was discharged on supplemental oxygen, Albuterol and Atrovent metered dose inhalers, as well as Flovent.
Endocrine:  At the time of admission, the patient was started on an insulin sliding scale to control her blood glucose.
She was also restarted on her thyroid hormone medicine.
On the day prior to discharge, she was restarted on her oral hypoglycemic agents, Avandia and Glucotrol.
DISCHARGE MEDICATIONS:  Protonix 80 mg po q day, Avandia 4.0 mg po q day, Glucotrol 10 mg po bid, thyroid hormone 2.0 mg po q day, Robitussin AC 10 mL po q four hours, Flovent 110 mcg two puffs [**Hospital1 **], Atrovent metered dose inhaler two puffs [**Hospital1 **], Albuterol metered dose inhaler two puffs q six hours, Avalide one tablet po q day.
